Isoform-specific binding of human apolipoprotein E to the non-amyloid beta component of Alzheimer's disease amyloid. (Q53216116)

12 May 2018

title

Isoform-specific binding of human apolipoprotein E to the non-amyloid beta component of Alzheimer's disease amyloid. (English)

1 reference

12 May 2018

1 reference

Olesen OF

1

1 reference

12 May 2018

Mikkelsen JD

series ordinal

2

1 reference

12 May 2018

Gerdes C

series ordinal

3

1 reference

12 May 2018

Jensen PH

series ordinal

4

1 reference

12 May 2018

publication date

1 February 1997

1 reference

12 May 2018

published in

Molecular Brain Research

1 reference

12 May 2018

volume

44

1 reference

12 May 2018

issue

1

1 reference

12 May 2018

page(s)

105-112

1 reference

12 May 2018

Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900196-9

7 January 2021

Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900196-9

7 January 2021

Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: evidence for a neuronal origin.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900196-9

7 January 2021

Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900196-9

7 January 2021

The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900196-9

7 January 2021

Amyloid beta-peptide is produced by cultured cells during normal metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900196-9

7 January 2021

Non-A.beta. Component of Alzheimer's Disease Amyloid (NAC) is Amyloidogenic

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900196-9

7 January 2021

Residues in the synuclein consensus motif of the α-synuclein fragment, NAC, participate in transglutaminase-catalysed cross-linking to Alzheimer-disease amyloid βA4 peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900196-9

7 January 2021

Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900196-9

7 January 2021

Amyloid plaque core protein in Alzheimer disease and Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900196-9

7 January 2021

Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900196-9

7 January 2021

Identification of glutamine and lysine residues in Alzheimer amyloid beta A4 peptide responsible for transglutaminase-catalysed homopolymerization and cross-linking to alpha 2M receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900196-9

7 January 2021

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900196-9

7 January 2021

The molecular pathology of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900196-9

7 January 2021

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900196-9

7 January 2021

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900196-9

7 January 2021

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900196-9

7 January 2021

Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900196-9

7 January 2021

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900196-9

7 January 2021

10.1016/S0169-328X(96)00196-9

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018